ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ORCHPHARMA_BE announcements Orchid Pharma Limited announcements and dividends declared NSE

Orchid Pharma Limited Complete list of announcements declared & dividend announcements by Orchid Pharma Limited ORCHPHARMA_BE

Orchid Pharma Limited ORCHPHARMA_BE listed on NSE and deals in

Announcements and dividends declared by Orchid Pharma Limited ORCHPHARMA_BE

Breakdown Stocks: How to trade Orchid Pharma, Everest Industries and Jai Corp that hit a 52-week low?
Indian markets rebounded strongly on Tuesday, with the Sensex surging over 1,000 points and Nifty crossing 22,500, led by gains in capital goods, telecom, and oil & gas sectors.
Announcement as on 08 April 2025

Stocks in news: Cyient, Waaree Energies, BSE, Tata Technologies, Orchid Pharma
Shares of IREDA and Tata Technologies will be in focus after an NSE release confirmed the inclusion of these in the futures and options segment from February 28.
Announcement as on 20 February 2025

Orchid Pharma partners with Cipla for pan-India distribution of Cefepime-Enmetazobactam
Orchid Pharma said that it has partnered with Cipla to ensure widespread and rapid distribution of the company's new drug- Cefepime-Enmetazobactam across India.
Announcement as on 29 June 2024

Orchid Pharma partners with Cipla to launch antibiotic drug - Cefepime-Enmetazobactam in India
Orchid Pharma announced the launch of its new drug - Cefepime-Enmetazobactam, which has been approved for the treatment of complicated Urinary Tract infections (cUTI), Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) indications.
Announcement as on 28 June 2024

Debt-free Orchid Pharma charts out growth plan
Orchid Pharma, backed by Dhanuka Group, focuses on cephalosporin antibiotics. Expansion plans include a new facility, Enmetazobactam launch, and mergers for sustainable growth and reduced import reliance.
Announcement as on 24 April 2024

Announcements by Orchid Pharma Limited first page | Next page |

ORCHPHARMA_BE Orchid Pharma Limited current price & indicator signals

Moving Averages for Orchid Pharma Limited

  • 5Day Average: 523.16
  • 12Day Average: 523.95
  • 20Day Average: 532.54
  • 50Day Average: 552.99
  • 100Day Average: 504.48
  • 150Day Average: 467.62
  • 200Day Average: 444.33

ORCHPHARMA_BE Indicators & signals

Indicator MACD (12,26,9)

527, 534.23, -7.94
Indicator MACD is in negative zone

Indicator ADX (14)

15.31, 14.37, 19.56
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ORCHPHARMA_BE Orchid Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
29 Fri Sep 2023 531.80 516.20 to 546.00 0.73% 1.44 times
28 Thu Sep 2023 527.95 508.50 to 544.00 -1.36% 4.01 times
27 Wed Sep 2023 535.25 510.25 to 535.25 4.99% 5.2 times
26 Tue Sep 2023 509.80 508.00 to 523.00 -0.23% 0.09 times
25 Mon Sep 2023 511.00 510.00 to 524.00 0.1% 0.08 times
22 Fri Sep 2023 510.50 500.10 to 524.90 -1.43% 0.1 times
21 Thu Sep 2023 517.90 514.95 to 532.00 -1.34% 0.1 times
20 Wed Sep 2023 524.95 520.65 to 530.70 -0.51% 0.05 times
18 Mon Sep 2023 527.65 525.05 to 534.00 -1.11% 0.07 times
15 Fri Sep 2023 533.55 511.50 to 539.00 0.27% 0.1 times
14 Thu Sep 2023 532.10 525.00 to 541.90 1.35% 0.2 times
13 Wed Sep 2023 525.00 502.00 to 530.40 1.61% 0.22 times

Videos related to: ORCHPHARMA_BE announcements Orchid Pharma Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

ORCHPHARMA_BE announcements Orchid Pharma Limited announcements and dividends declared NSE

 

Back to top